COP vs CTOR
ConocoPhillips (COP) versus Citius Oncology, Inc. (CTOR) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
CTOR does not have a complete income-statement cache yet.
COP currently screens at market cap $135.49B and trailing P/E 18.8. CTOR currently screens at market cap $105.2M.
Not investment advice. Open the COP and CTOR stock pages for the full models.
Not investment advice.